Skip to content Skip to navigation

Human Microsurgery

We use evidence-based approaches to study and improve surgery for our patients. Once surgeons and scientists have a molecular target in their sights, numerous molecular drugs are available to them. These may involve enzymes, genes, antibodies, or chemicals. Eye surgeons can precisely and safely deliver any of these molecules near specific cells in the eye, avoiding the toxicity and issues associated with drugs taken by mouth or injected into the blood stream. Once delivered, patients can be observed noninvasively in the clinic using ultra-high-resolution cameras.

Projects

A multi-institution precision health consortium for collecting ophthalmic surgical samples.

We conducted laboratory and clinical studies on macular hole repair.

We conduct studies to develop safer, more efficient surgery in patients.

Evidence-based approaches for new surgical treatments and research to discover the molecular causes.

News

Oct 27 2018 | Posted In: 20/20 Blog
Chicago, IL —Angela Li, a second year Stanford medical student working in the Mahajan lab, presented a poster, “Proteomic Analysis of Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy,” at the 2018 American Academy of Ophthalmology (AAO) m
Sep 26 2018 | Posted In: 20/20 Blog
Palo Alto, CA — Physicians, scientists, engineers, entrepreneurs, and patients are collaborating in an effort to move ophthalmology away from symptom-based, trial and error approaches to personalized treatment plans. 
Sep 19 2018 | Posted In: 20/20 Blog
Dayton, OH — In the fall, Trisha Kulkarni will join the Stanford University freshman class and will no longer have to get on a plane to see Dr. Mahajan for eye exams, but that doesn’t mean she won’t be flying high. With Trisha, the sky is the limit. 
Sep 11 2018 | Posted In: 20/20 Blog
Palo Alto, CA — Patients with diabetes suffer ongoing damage to their retina that can result in blindness. Oxidative chemicals produced in the eye are a key factor. 
Jul 12 2018 | Posted In: 20/20 Blog
Palo Alto, CA — Dr. Vinit Mahajan and Dr.